Thioalbamide inhibits FoF1-ATPase in breast cancer cells and reduces tumor proliferation and invasiveness in breast cancer in vivo models. (2023)
Attributed to:
Harnessing the biosynthetic potential of bacteria to produce ribosomally synthesised natural products
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.molmet.2023.101674
PubMed Identifier: 36657563
Publication URI: http://europepmc.org/abstract/MED/36657563
Type: Journal Article/Review
Volume: 68
Parent Publication: Molecular metabolism
ISSN: 2212-8778